Fibrosis: all 1,270 studies
Page 10 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Establishing Lymphedema and Fibrosis Measures in Oral Cancer PatientsCompletedNCT02412241Not applicable
- Utility of Prolonged-release Pirfenidone in the Progression of Chronic Kidney DiseaseCompletedNCT02408744Phase 1/2
- International T1 Multicentre CMR Outcome StudyCompletedNCT02407197
- Albumin Infusion Effects in Mortality in Patients With Cirrhosis and Hepatic EncephalopathyStatus unknownNCT02401490Phase 4
- Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver FibrosisCompletedNCT02400216
- A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent AscitesCompletedNCT02400164Not applicable
- Effects of Local Insulin on Wound AngiogenesisStatus unknownNCT02396888Phase 3
- Relationship Between HbA1c and Chronic Glycemia in Patients With CirrhosisCompletedNCT02389127
- Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated BoostActive, not recruitingNCT02384733Not applicable
- A Pilot Study: Defining Peripheral Endothelial Function in Portal Hypertensive Cirrhotic PatientsWithdrawnNCT02356250
- Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.CompletedNCT02352181Not applicable
- Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver CirrhosisStatus unknownNCT02344823Phase 4
- Effect of Taurine on Portal Hemodynamics in Patients With Advanced Liver CirrhosisCompletedNCT02344719Phase 4
- Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis PatientsStatus unknownNCT02327689Phase 4
- Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic HepatitisCompletedNCT02326103Early Phase 1
- Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver CancerCompletedNCT02321202Phase 4
- Primary Prevention Hepatocellular Carcinoma by MetforminTerminatedNCT02319200Phase 3
- Cirrhosis Readmission Telehealth ProjectTerminatedNCT02313896Not applicable
- ShearWave™ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis BCompletedNCT02313649
- Insertion Technique in Large Volume ParacentesisCompletedNCT02310165Not applicable
- Knee Stiffness in Fibrosis DiathesisStatus unknownNCT02294890
- Portal Vein Thrombosis in CirrhosisWithdrawnNCT02275585
- A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using BiomarkersCompletedNCT02272504
- Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic PatientsSuspendedNCT02271295Phase 3
- Effects of Home Based Exercise Therapy in Early CirrhosisCompletedNCT02267421Not applicable
- Utilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver ProgressionCompletedNCT02267148
- The Use of Transient Elastography to Predict Clinical Decompensation in Patients With Early CirrhosisWithdrawnNCT02258048
- Predictive Factors and Outcome of Esophageal Ulcers After Endoscopic Treatment of Esophageal VaricesStatus unknownNCT02256046Not applicable
- Prospective Study of Profile of Hepatic Osteodystrophy in Patients With Non-Choleastatic Liver Cirrhosis and Impact of Bisphosphonate SupplementationCompletedNCT02249741Phase 4
- Follow-up of HBsAg Inactive Carriers StudyCompletedNCT02247752Not applicable
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedNCT02247414Phase 4
- A Trial Comparing Entacavir and Tenofovir in Patients With HBV Decompensated CirrhosisStatus unknownNCT02238860Phase 4
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic SplenectomyStatus unknownNCT02238444Phase 4
- Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-LStatus unknownNCT02232490Phase 3
- An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced CirrhosisCompletedNCT02195440Phase 1
- Rifaximin Reduces the Complications of Decompensated Cirrhosis: a Randomized Controlled TrialStatus unknownNCT02190357Phase 4
- The Role of Strain Elastography in Staging Liver FibrosisStatus unknownNCT02184000
- Liver Fibrosis Assessment With ShearWave ElastographyCompletedNCT02181452
- Spleen Stiffness Measurement With FibroScanCompletedNCT02180113Not applicable
- Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent AscitesCompletedNCT02173288Phase 2/3
- Pirfenidone, an Antifibrotic and Antiinflammatory DrugCompletedNCT02161952Phase 2
- Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal BleedingCompletedNCT02158182Phase 4
- iPod Games in Hepatic EncephalopathyCompletedNCT02154282Not applicable
- LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 CirrhosisCompletedNCT02151864Phase 1
- Evaluation of Renal Blood Flow Using Contrast Enhanced Ultrasound for Differential Diagnosis of Acute Kidney Injury in Cirrhotic Patients: A Pilot StudyStatus unknownNCT02147470Not applicable
- Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT02143401Phase 1
- The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted RecipientsCompletedNCT02134899Phase 3
- Sarcopenia and CirrhosisCompletedNCT02132962Not applicable
- Hepatic Fibrosis Non-invasive Methods QuestionnaireCompletedNCT02132351
- Telomeres Parameters in CirrhosisStatus unknownNCT02131831
- PROLIFICA - West African Treatment Cohort for Hepatitis BCompletedNCT02129829
- Comparative Effectiveness and Tolerability of Boceprevir vs TelaprevirCompletedNCT02113631Not applicable
- Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney InjuryCompletedNCT02097784Not applicable
- MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent AnemiasCompletedNCT02090699
- Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy OutcomeCompletedNCT02083367
- IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie sévèreCompletedNCT02078076Not applicable
- Rifaximin Predicts the Complications of Decompensated CirrhosisStatus unknownNCT02074280Phase 4
- Zinc Supplementation in Alcoholic CirrhosisCompletedNCT02072746Not applicable
- Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD)CompletedNCT02061254Not applicable
- Mesenchymal Stromal Cell Therapy in Renal RecipientsStatus unknownNCT02057965Phase 2
- Selection Criteria for Safe Hepatectomy for Hepatocellular CarcinomaCompletedNCT02056041
- Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With CirrhosisStatus unknownNCT02049125
- Noninvasive Staging of Liver Fibrosis: MR vs UltrasoundCompletedNCT02044523
- The INFECIR-2 Albumin Prevention StudyTerminatedNCT02034279Phase 4
- Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)TerminatedNCT02026609
- Randomised Controlled Trial of Mechanistic Effects of Rifaximin in Cirrhosis and Chronic Hepatic EncephalopathyCompletedNCT02019784Phase 4
- Comparison Between Lactulose and Lactulose-Paraffin in Cirrhotic PatientsCompletedNCT02017119Phase 2
- Rifaximin vs Placebo for the Prevention of Encephalopathy in Patients Treated by TIPSCompletedNCT02016196Phase 3
- Alpha-1 Antitrypsin Deficiency Adult Liver StudyActive, not recruitingNCT02014415
- Vitamin D Supplementation in Cirrhotic PatientsCompletedNCT02009748Phase 2
- Pathophysiology of Dilated CardiomyopathyWithdrawnNCT02001961
- Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With CirrhosisStatus unknownNCT01992978Not applicable
- Observation Study of Prednisone and Cyclosporine in Treatment of Thrombocytopenia in Hepatitis B CirrhosisStatus unknownNCT01987791
- Prospective Study of Urinary Markers of Fibrosis in Kidney TransplantsStatus unknownNCT01982903
- Study to Evaluate Fractional Collagen Synthesis Within Keloid Scars and Identify Biomarkers of Keloid ScarsTerminatedNCT01978301Phase 1
- Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive ParametersCompletedNCT01962155
- Galectin-3 Blockade in Patients With High Blood PressureCompletedNCT01960946Not applicable
- Effects of Aerobic Training on Exercise Capacity in Patients With Advanced Cirrhosis 2CompletedNCT01960127Not applicable
- Study of High-Dose Oral Vitamin D for the Prevention of Liver CancerWithdrawnNCT01956864Phase 1
- A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With CirrhosisTerminatedNCT01954524Phase 1
- Pilot Study Of The Effect Of Rifaximin On B-Cell Dysregulation In CirrhosisTerminatedNCT01951209Not applicable
- Real Time Elastography in Liver FibrosisStatus unknownNCT01948687
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisCompletedNCT01934777Phase 3
- LIVER FIBROSIS PREVALENCE IN FRANCEStatus unknownNCT01927133
- Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)WithdrawnNCT01923376Not applicable
- Pilot Study of the Effect of Laser on Reversing Chronic Radiation InjuryActive, not recruitingNCT01910818Not applicable
- Quantitative Liver Function Tests Using CholatesTerminatedNCT01907074Phase 2
- Assessment Of Liver and Spleen Fibrosis in Patients With Gaucher Disease Using FibroscanStatus unknownNCT01898325Not applicable
- PROPRANOLOL PLUS LIGATION REDUCES RECURRENCE OF ESOPHAGEAL VARICES?CompletedNCT01893541Phase 4
- Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic CirrhosisCompletedNCT01884415Phase 3
- Effect of Music on Attention and Prospective Memory in Hepatic EncephalopathyWithdrawnNCT01882855
- Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver FailureCompletedNCT01872767
- Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver CirrhosisStatus unknownNCT01863121
- Validation of the Percentage of Alveolar Fibrocyte as Biomarker During ARDSCompletedNCT01854424
- MBT Versus HVPG in Identifying Responders to Portal Hypertension TherapyCompletedNCT01851252Phase 1
- Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartateCompletedNCT01847651Phase 4
- Factors Associated With End Stage Liver DiseaseTerminatedNCT01846819
- Angiogenesis and Fibrosis in Aortic StenosisCompletedNCT01837160
- Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)Status unknownNCT01830959Phase 4
- Treatment of Radiation-induced Fibrosis in the Upper Aerodigestive Tract Cancer by a Combination of Pentoxifylline-tocopherol and Hyperbaric OxygenStatus unknownNCT01822405Phase 2